Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Front Pharmacol. 2023 Feb 20:14:1155631. doi: 10.3389/fphar.2023.1155631. eCollection 2023.

Authors

Yu-Yang Liu¹, Yi-Yang Qu¹, Shang Wang¹, Ci-Jun Luo¹, Hong-Ling Qiu¹, Hui-Ting Li¹, Ping Yuan¹, Lan Wang¹, Jin-Ling Li^{1

2}, Rong Jiang¹, Rui Zhang²

Affiliations

¹ Department of Cardiopulmonary Circulation, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
² Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1052546.].

Keywords: meta, analysis; phosphodiesterase-5 inhibitor; pulmonary arterial hypertension; riociguat; systematic review.

Copyright © 2023 Liu, Qu, Wang, Luo, Qiu, Li, Yuan, Wang, Li, Jiang and Zhang.

Publication types

Published Erratum